PT1212060E - Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson - Google Patents
Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinsonInfo
- Publication number
- PT1212060E PT1212060E PT00960782T PT00960782T PT1212060E PT 1212060 E PT1212060 E PT 1212060E PT 00960782 T PT00960782 T PT 00960782T PT 00960782 T PT00960782 T PT 00960782T PT 1212060 E PT1212060 E PT 1212060E
- Authority
- PT
- Portugal
- Prior art keywords
- dopa
- nicotine
- parkinson
- disease
- derivatives
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9911029A FR2798065B1 (fr) | 1999-09-02 | 1999-09-02 | Utilisation de la nicotine ou de ses derives dans un medicament pour le traitement des maladies neurologiques, notamment la maladie de parkinson |
Publications (1)
Publication Number | Publication Date |
---|---|
PT1212060E true PT1212060E (pt) | 2005-08-31 |
Family
ID=9549506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT00960782T PT1212060E (pt) | 1999-09-02 | 2000-09-01 | Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson |
Country Status (10)
Country | Link |
---|---|
US (1) | US6911475B1 (pt) |
EP (1) | EP1212060B1 (pt) |
AT (1) | ATE292969T1 (pt) |
CA (1) | CA2383509C (pt) |
DE (1) | DE60019436T2 (pt) |
DK (1) | DK1212060T3 (pt) |
ES (1) | ES2241651T3 (pt) |
FR (1) | FR2798065B1 (pt) |
PT (1) | PT1212060E (pt) |
WO (1) | WO2001015696A1 (pt) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE253918T1 (de) | 1999-12-08 | 2003-11-15 | Centre Nat Rech Scient | Verwendung von hymenialdisin und dessen derivaten zur herstellung therapeutischer mittel |
WO2005039531A1 (en) * | 2003-10-10 | 2005-05-06 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
US7198801B2 (en) * | 2000-08-03 | 2007-04-03 | Antares Pharma Ipl Ag | Formulations for transdermal or transmucosal application |
US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
US20040198706A1 (en) * | 2003-03-11 | 2004-10-07 | Carrara Dario Norberto R. | Methods and formulations for transdermal or transmucosal application of active agents |
US8980290B2 (en) * | 2000-08-03 | 2015-03-17 | Antares Pharma Ipl Ag | Transdermal compositions for anticholinergic agents |
ES2283665T3 (es) * | 2000-08-03 | 2007-11-01 | Antares Pharma Ipl Ag | Composicion para administracion transdermica y/o transmucosa de compuestos activos que asegura unos niveles terapeuticamente adecuados. |
KR100421585B1 (ko) | 2001-10-25 | 2004-03-09 | 한국전자통신연구원 | 시간분할 듀플렉스 시스템에서 이동국의 셀 탐색 시스템및 그 방법 |
DE10338174A1 (de) | 2003-08-20 | 2005-03-24 | Lts Lohmann Therapie-Systeme Ag | Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit |
US7387788B1 (en) | 2003-10-10 | 2008-06-17 | Antares Pharma Ipl Ag | Pharmaceutical compositions of nicotine and methods of use thereof |
US7257577B2 (en) * | 2004-05-07 | 2007-08-14 | International Business Machines Corporation | System, method and service for ranking search results using a modular scoring system |
CA2580329C (en) | 2004-09-13 | 2015-01-06 | Chrono Therapeutics Inc. | Biosynchronous transdermal drug delivery |
US8252321B2 (en) | 2004-09-13 | 2012-08-28 | Chrono Therapeutics, Inc. | Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like |
US8067399B2 (en) | 2005-05-27 | 2011-11-29 | Antares Pharma Ipl Ag | Method and apparatus for transdermal or transmucosal application of testosterone |
KR100699582B1 (ko) | 2005-07-11 | 2007-03-23 | 삼성전기주식회사 | 출력 버퍼회로 |
CA2646667C (en) * | 2006-04-21 | 2014-03-11 | Antares Pharma Ipl Ag | Methods of treating hot flashes with formulations for transdermal or transmucosal application |
WO2008067991A2 (en) * | 2006-12-08 | 2008-06-12 | Antares Pharma Ipl Ag | Skin-friendly drug complexes for transdermal administration |
EP2322167A1 (en) * | 2007-04-02 | 2011-05-18 | Parkinson's Institute | Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments |
AU2011203482B2 (en) * | 2007-04-02 | 2014-09-04 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
WO2013006643A1 (en) | 2011-07-06 | 2013-01-10 | The Parkinson's Institute | Compositions and methods for treatment of symptoms in parkinson's disease patients |
US9463186B2 (en) | 2013-04-15 | 2016-10-11 | Northwestern University | Treatment for dopaminergic disorders |
AU2016211330A1 (en) | 2015-01-28 | 2017-08-03 | Chrono Therapeutics Inc. | Drug delivery methods and systems |
WO2016145373A1 (en) | 2015-03-12 | 2016-09-15 | Chrono Therapeutics Inc. | Craving input and support system |
US10292977B2 (en) | 2016-04-11 | 2019-05-21 | Neurocea, LLC | Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases |
US10143687B2 (en) | 2016-04-11 | 2018-12-04 | Neurocea, LLC | Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases |
EP3565617A1 (en) | 2017-01-06 | 2019-11-13 | Chrono Therapeutics Inc. | Transdermal drug delivery devices and methods |
US11596779B2 (en) | 2018-05-29 | 2023-03-07 | Morningside Venture Investments Limited | Drug delivery methods and systems |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5242935A (en) | 1992-03-06 | 1993-09-07 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
US5232933A (en) * | 1992-05-21 | 1993-08-03 | R. J. Reynolds Tobacco Company | Method for treatment of neurodegenerative diseases |
-
1999
- 1999-09-02 FR FR9911029A patent/FR2798065B1/fr not_active Expired - Fee Related
-
2000
- 2000-09-01 US US09/653,717 patent/US6911475B1/en not_active Expired - Lifetime
- 2000-09-01 EP EP00960782A patent/EP1212060B1/fr not_active Expired - Lifetime
- 2000-09-01 CA CA2383509A patent/CA2383509C/fr not_active Expired - Fee Related
- 2000-09-01 WO PCT/FR2000/002428 patent/WO2001015696A1/fr active IP Right Grant
- 2000-09-01 ES ES00960782T patent/ES2241651T3/es not_active Expired - Lifetime
- 2000-09-01 DE DE60019436T patent/DE60019436T2/de not_active Expired - Lifetime
- 2000-09-01 AT AT00960782T patent/ATE292969T1/de active
- 2000-09-01 DK DK00960782T patent/DK1212060T3/da active
- 2000-09-01 PT PT00960782T patent/PT1212060E/pt unknown
Also Published As
Publication number | Publication date |
---|---|
CA2383509C (fr) | 2012-08-14 |
ES2241651T3 (es) | 2005-11-01 |
DE60019436D1 (de) | 2005-05-19 |
FR2798065B1 (fr) | 2003-09-05 |
ATE292969T1 (de) | 2005-04-15 |
EP1212060B1 (fr) | 2005-04-13 |
DK1212060T3 (da) | 2005-08-15 |
US6911475B1 (en) | 2005-06-28 |
DE60019436T2 (de) | 2006-02-02 |
WO2001015696A1 (fr) | 2001-03-08 |
EP1212060A1 (fr) | 2002-06-12 |
FR2798065A1 (fr) | 2001-03-09 |
CA2383509A1 (fr) | 2001-03-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT1212060E (pt) | Utilizacao de nicotina ou dos seus derivados e de l-dopa num medicamento para o tratamento de doencas neurologicas, em especial a doenca de parkinson | |
Urban et al. | Long-term use of narcotic/antidepressant medication in the management of phantom limb pain | |
NL970006I1 (nl) | Gebruik van indolon-derivaten voor het bereiden van geneesmiddelen ter behandeling van de ziekte vanParkinson. | |
BR9306841A (pt) | Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico | |
CY1111088T1 (el) | Θεραπευτικη φαρμακοτεχνικη μορφη για χορηγηση τολτεροδινης με ελεγχομενη απελευθερωση | |
JPH0222229A (ja) | 神経細胞及び神経繊維の疾患もしくは傷害の治療に用いる組み合わせ調合剤 | |
JP2002502871A5 (pt) | ||
EP1201246A3 (en) | Use of Thrombopoietin as a medicament for the therapy and prevention of thrombocytopenia | |
JPH05504546A (ja) | 痛みのある疾患又はアレルギー性疾患の治療用組成物及び治療法 | |
GB2285219B (en) | Use of norastemizole for the treatment of allergic disorders | |
BR9913746C1 (pt) | Derivado de piridìnio, processo para a preparação do mesmo, uso do mesmo, composição farmacêutica, processo para preparação de uma formulação parenteral,e, métodos de tratamento de um paciente diabético e de prevenção ou de tratamento de doenças causadas por diabetes e por complicações relacionadas com o envelhecimento | |
JPH0637395B2 (ja) | ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤 | |
WO2001012214A3 (en) | MYCOPHENOLATE MOFETIL IN ASSOCIATION WITH PEG-IFN-$g(a) | |
KR100420673B1 (ko) | 지연된구토반응을치료하기위한비강투여제 | |
BR9809396A (pt) | Método de tratamento de doenças de cicatrização vascular progressivas | |
WO1996030016A3 (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases | |
KR900007434A (ko) | 시스타틴을 유효 성분으로하는 치료제 | |
CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
KR970005283A (ko) | 심근경색발생 후의 환자를 처치하기 위한 서트랄린의 용도 | |
RU2002129298A (ru) | Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера | |
AU2002255389B2 (en) | Method for treatment of neurodegenerations | |
ATE91890T1 (de) | Herstellung eines arzneimittels gegen arthritis und rheumatismus. | |
JP2002529515A5 (pt) | ||
JP2609882B2 (ja) | 脱髄性疾患治療薬 | |
KR930019207A (ko) | 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도 |